Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Anti-NMDAR-encefalitis: betere uitkomsten door sneller en agressiever behandelen
feb 2020